nach oben

Journal of Community Health

Erschienen in:

04.02.2020 | Original Paper

Misinformation, Gendered Perceptions, and Low Healthcare Provider Communication Around HPV and the HPV Vaccine Among Young Sexual Minority Men in New York City: The P18 Cohort Study

verfasst von: Jessica Jaiswal, Caleb LoSchiavo, Anthony Maiolatesi, Farzana Kapadia, Perry N. Halkitis

Erschienen in: Journal of Community Health | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Human papillomavirus (HPV) is the most common sexually transmitted infection among adults in the United States, and can cause several types of cancer. This is of particular concern for sexual minority men, as their increased risk of HIV acquisition increases risk for HPV and HPV-associated cancers, particularly when coupled with low rates of HPV vaccination. As part of a larger study of the syndemic of HIV, substance use, and mental health among young sexual minority men in New York City, we sought to explore what sexual minority men know about HPV and the HPV vaccine, along with their experiences have been communicating about the virus and vaccine. We interviewed 38 young sexual minority men with diverse sociodemographic characteristics and identified three main themes: low knowledge about HPV infection and vaccination, highly gendered misconceptions about HPV only affecting women, and lack of communication from healthcare providers about HPV. The prevalence of incorrect HPV knowledge, coupled with inadequate education and vaccination in healthcare settings, indicates a missed opportunity for HPV prevention in a high-risk and high-need population.

Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., Ocfemia, M. C. B., et al. (2013). Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008. Sexually Transmitted Diseases,40(3), 187–193.PubMed

McQuillan, G. M., Kruszon-Moran, D., Markowitz, L. E., Unger, E. R., & Paulose-Ram, R. (2017). Prevalence of HPV in adults aged 18–69: United States, 2011–2014 [NCHS data brief, no. 280]. Hyattsville: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics.

Dunne, E. F., Unger, E. R., Sternberg, M., McQuillan, G., Swan, D. C., Patel, S. S., et al. (2007). Prevalence of HPV infection among females in the United States. JAMA,297(8), 813–819.PubMed

Dunne, E. F., Nielson, C. M., Stone, K. M., Markowitz, L. E., & Giuliano, A. R. (2006). Prevalence of HPV infection among men: A systematic review of the literature. Journal of Infectious Diseases, 194(8), 1044–1057.PubMed

Cates, W. (1999). Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sexually Transmitted Diseases, 26(4S), S2–S7.PubMed

Hoots, B. E., Palefsky, J. M., Pimenta, J. M., & Smith, J. S. (2009). Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. International Journal of Cancer, 124(10), 2375–2383.PubMed

Smith, J. S., Backes, D. M., Hoots, B. E., Kurman, R. J., & Pimenta, J. M. (2009). Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstetrics & Gynecology, 113(4), 917–924.

Muñoz, N., Bosch, F. X., de Sanjose, S., Herrero, R., Castellsagué, X., Shah, K. V., et al. (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine,348(6), 518–527.PubMed

Muñoz, N., Castellsagué, X., de González, A. B., & Gissmann, L. (2006). HPV in the etiology of human cancer. Vaccine, 24(S3), S1–S10.

10.

Gross, G., & Pfister, H. (2004). Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Medical Microbiology and Immunology, 193(1), 35–44.PubMed

11.

McNamara, M., Batur, P., Walsh, J. M. E., & Johnson, K. M. (2016). HPV update: Vaccination, screening, and associated disease. Journal of General Internal Medicine, 31(11), 1360–1366.PubMedPubMedCentral

12.

Food and Drug Administration, United States. (2018). FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old [press release]. Retrieved from https://www.fda.gov/news-events/press-announcements/fda-approves-expanded-use-gardasil-9-include-individuals-27-through-45-years-old.

13.

Reiter, P. L., Gilkey, M. B., & Brewer, N. T. (2013). HPV vaccination among adolescent males: Results from the National Immunization Survey-Teen. Vaccine,31(26), 2816–2821.PubMedPubMedCentral

14.

Gilkey, M. B., Moss, J. L., McRee, A. L., & Brewer, N. T. (2012). Do correlates of HPV vaccine initiation differ between adolescent boys and girls? Vaccine, 30(41), 5928–5934.PubMedPubMedCentral

15.

Holman, D. M., Benard, V., Roland, K. B., Watson, M., Liddon, N., & Stokley, S. (2014). Barriers to human papillomavirus vaccination among US adolescents: A systematic review of the literature. JAMA Pediatrics, 168(1), 76–82.PubMedPubMedCentral

16.

Reiter, P. L., McRee, A. L., Katz, M. L., & Paskett, E. D. (2015). Human papillomavirus vaccination among young adult gay and bisexual men in the United States. American Journal of Public Health, 105(1), 96–102.PubMedPubMedCentral

17.

Reiter, P. L., Brewer, N. T., McRee, A. L., Gilbert, P., & Smith, J. S. (2010). Acceptability of HPV vaccine among a national sample of gay and bisexual men. Sexually Transmitted Diseases, 37(3), 197–203.PubMedPubMedCentral

18.

Gerend, M. A., Madkins, K., Phillips, G., & Mustanski, B. (2016). Predictors of human papillomavirus vaccination among young men who have sex with men. Sexually Transmitted Diseases, 43(3), 185–191.PubMedPubMedCentral

19.

Nyitray, A. G., Carvalho da Silva, R. J., Baggio, M. L., Lu, B., Smith, D., Abrahamsen, M., et al. (2011). Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: The HPV in Men (HIM) study. Journal of Infectious Diseases,203(1), 49–57.PubMed

20.

Oliver, S. E., Hoots, B. E., Paz-Bailey, G., Markowitz, L. E., Meites, E., & NS Group. (2017). Increasing human papillomavirus vaccine coverage among men who have sex with men—National HIV Behavioral Surveillance, United States, 2014. JAIDS,75(S3), S370–S374.PubMed

21.

Meites, E., Gorbach, P. M., Gratzer, B., Panicker, G., Steinau, M., Collins, T., et al. (2016). Monitoring for human papillomavirus vaccine impact among gay, bisexual, and other men who have sex with men—United States, 2012–2014. Journal of Infectious Diseases,214(5), 689–696.PubMed

22.

Charlton, B. M., Reisner, S. L., Agenor, M., Gordon, A. R., Sarda, V., & Austin, S. B. (2017). Sexual orientation disparities in human papillomavirus vaccination in a longitudinal cohort of U.S. males and females. LGBT Health, 4(3), 202–209.PubMedPubMedCentral

23.

Bednarczyk, R. A., Whitehead, J. L., & Stephenson, R. (2017). Moving beyond sex: Assessing the impact of gender identity on human papillomavirus vaccine recommendations and uptake among a national sample of rural-residing LGBT young adults. Papillomavirus Research, 3, 121–125.PubMedPubMedCentral

24.

Apaydin, K. Z., Fontenot, H. B., Shtasel, D., Dale, S. K., Borba, C. P., Lathan, C. S., et al. (2018). Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center. Vaccine,36(26), 3868–3875.PubMedPubMedCentral

25.

Halkitis, P. N., Valera, P., LoSchiavo, C. E., Goldstone, S. E., Kanztanou, M., Maiolatesi, A. J., et al. (2019). Human papillomavirus vaccination and infection in young sexual minority men: The P18 Cohort Study. AIDS Patient Care and STDs,33(4), 149–156.PubMedPubMedCentral

26.

Meites, E., Markowitz, L. E., Paz-Bailey, G., & Oster, A. M. (2014). HPV vaccine coverage among men who have sex with men—National HIV Behavioral Surveillance System, United States, 2011. Vaccine, 32(48), 6356–6359.PubMedPubMedCentral

27.

Chin-Hong, P. V., Husnik, M., Cranston, R. D., Colfax, G., Buchbinder, S., Da Costa, M., et al. (2009). Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS,23(9), 1135.PubMedPubMedCentral

28.

Rositch, A. F., Gravitt, P. E., & Smith, J. S. (2013). Growing evidence that HPV infection is associated with an increase in HIV acquisition: Exploring the issue of HPV vaccination. BMJ Sexually Transmitted Infections, 89(5), 357.

29.

Houlihan, C. F., Larke, N. L., Watson-Jones, D., Smith-McCune, K. K., Shiboski, S., Gravitt, P. E., et al. (2012). Human papillomavirus infection and increased risk of HIV acquisition: A systematic review and meta-analysis. AIDS,26(17), 2211–2222.PubMed

30.

Bennetts, L. E., Wagner, M., Giuliano, A. R., Palefsky, J. M., Steben, M., & Weiss, T. W. (2015). Associations of anogenital low-risk human papillomavirus infection with cancer and acquisition of HIV. Sexually Transmitted Diseases, 42(10), 541–544.PubMed

31.

Lissouba, P., Van de Perre, P., & Auvert, B. (2013). Association of genital human papillomavirus infection with HIV acquisition: A systematic review and meta-analysis. Sexually Transmitted Infections, 89(5), 350–356.PubMedPubMedCentral

32.

Chin-Hong, P. V., & Palefsky, J. M. (2005). Human papillomavirus anogenital disease in HIV-infected individuals. Dermatological Therapy, 18(1), 67–76.

33.

Palefsky, J. M. (2006). Biology of HPV in HIV infection. Advances in Dental Research, 19(1), 99–105.PubMed

34.

Gormley, R. H., & Kovarik, C. L. (2009). Dermatologic manifestations of HPV in HIV-infected individuals. Current HIV/AIDS Reports, 6(3), 130–138.PubMed

35.

Cummings, T., Kasting, M. L., Rosenberger, J. G., Rosenthal, S. L., Zimet, G. D., & Stupiansky, N. W. (2015). Catching up or missing out? Human papillomavirus vaccine acceptability among 18- to 26-year-old men who have sex with men in a US national sample. Sexually Transmitted Diseases, 42(11), 601–606.PubMed

36.

Newman, P. A., Logie, C. H., Doukas, N., & Asakura, K. (2013). HPV vaccine acceptability among men: A systematic review and meta-analysis. Sexually Transmitted Infections, 89(7), 568.PubMedPubMedCentral

37.

Brewer, N. T., Ng, T. W., McRee, A. L., & Reiter, P. L. (2010). Men’s beliefs about HPV-related disease. Journal of Behavioral Medicine, 33(4), 274–281.PubMedPubMedCentral

38.

Stupiansky, N. W., Alexander, A. B., & Zimet, G. D. (2012). Human papillomavirus vaccine and men: What are the obstacles and challenges? Current Opinion in Infectious Diseases, 25(1), 86–91.PubMed

39.

Luk, J. W., Gilman, S. E., Haynie, D. L., & Simons-Morton, B. G. (2017). Sexual orientation differences in adolescent health care access and health-promoting physician advice. Journal of Adolescent Health, 61(5), 555–561.PubMed

40.

Ward, B. W., Dahlhamer, J. M., Galinsky, A. M., & Joestl, S. S. (2014). Sexual orientation and health among U.S. adults: National Health Interview Survey. 2013. National Health Statistics Report, 77, 1–10.

41.

LaVeist, T. A., Nickerson, K. J., & Bowie, J. V. (2000). Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Medical Care Research and Review, 57(S1), 146–161.PubMed

42.

LaVeist, T. A. (2005). Disentangling race and socioeconomic status: A key to understanding health inequalities. Journal of Urban Health,82(2 Supp 3), iii26–iii34.PubMedPubMedCentral

43.

LaVeist, T. A., Isaac, L. A., & Williams, K. P. (2009). Mistrust of health care organizations is associated with underutilization of health services. Health Services Research, 44(6), 2093–2105.PubMedPubMedCentral

44.

Khalili, J., Leung, L. B., & Diamant, A. L. (2015). Finding the perfect doctor: Identifying lesbian, gay, bisexual, and transgender-competent physicians. American Journal of Public Health, 105(6), 1114–1119.PubMedPubMedCentral

45.

Moll, J., Krieger, P., Moreno-Walton, L., Lee, B., Slaven, E., James, T., et al. (2014). The prevalence of lesbian, gay, bisexual, and transgender health education and training in emergency medicine residency programs: What do we know? Academic Emergency Medicine,21(5), 608–611.PubMed

46.

Nowaskie, D. Z., & Sowinski, J. S. (2018). Primary care providers’ attitudes, practices, and knowledge in treating LGBTQ communities. Journal of Homosexuality, 66(13), 1927–1947.PubMed

47.

Halkitis, P. N., Kapadia, F., Bub, K. L., Barton, S., Moreira, A. D., & Stults, C. B. (2015). A longitudinal investigation of syndemic conditions among young gay, bisexual, and other MSM: The P18 cohort study. AIDS and Behavior, 19(6), 970–980.PubMedPubMedCentral

48.

Halkitis, P. N., Moeller, R. W., Siconolfi, D. E., Storholm, E. D., Solomon, T. M., & Bub, K. L. (2013). Measurement model exploring a syndemic in emerging adult gay and bisexual men. AIDS and Behavior, 17(2), 662–673.PubMedPubMedCentral

49.

Paul, G., Noel, T. B., Paul, L. R., Terence, W. N., & Jennifer, S. S. (2010). HPV vaccine acceptability in heterosexual, gay, and bisexual men. American Journal of Men's Health, 5(4), 297–305.

50.

Wheldon, C. W., Daley, E. M., Buhi, E. R., Nyitray, A. G., & Giuliano, A. R. (2011). Health beliefs and attitudes associated with HPV vaccine intention among young gay and bisexual men in the southeastern United States. Vaccine, 29(45), 8060–8065.PubMed

51.

Halkitis, P. N., Kapadia, F., Ompad, D. C., & Perez-Figueroa, R. (2015). Moving toward a holistic conceptual framework for understanding healthy aging among gay men. Journal of Homosexuality, 62(5), 571–587.PubMed

52.

Halkitis, P. N. (2010). Reframing HIV prevention for gay men in the United States. American Psychologist, 65(8), 752–763.PubMed

53.

Halkitis, P. N., Cook, S. H., Ristuccia, A., Despotoulis, J., Levy, M. D., Bates, F. C., et al. (2018). Psychometric analysis of the life worries scale for a new generation of sexual minority men: The P18 Cohort Study. Health Psychology,37(1), 89–101.PubMed

54.

Halkitis, P. N. (2013). The AIDS generation: Stories of survival and resilience. New York: Oxford University Press.

55.

Halkitis, P. N. (2019). Out in time: From Stonewall to queer, how gay men came of age across the generations. New York: Oxford University Press.

56.

Goedel, W. C., King, M. R. F., Lurie, M. N., Nunn, A. S., Chan, P. A., & Marshall, B. D. L. (2019). Effect of racial inequities in pre-exposure prophylaxis use on racial disparities in HIV incidence among men who have sex with men: A modeling study. JAIDS,79(3), 323–329.

57.

Misra, K., Huang, J. S., & Udeagu, C. (2019). Ongoing disparities in prediagnosis preexposure prophylaxis use among persons recently diagnosed with HIV in New York City, 2015–2017. American Journal of Public Health, 109(9), 1212–1215.PubMed

58.

Crepaz, N., Dong, X., Wang, X., Hernandez, A. L., & Hall, H. I. (2018). Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons receiving HIV care—United States, 2014. Morbidity and Mortality Weekly Report, 67(4), 113–118.PubMedPubMedCentral

59.

Giuliano, A. R., Joura, E. A., Garland, S. M., Huh, W. K., Iversen, O. E., Kjaer, S. K., et al. (2019). Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: Comparison with historic placebo population. Gynecologic Oncology,154(1), 110–117.PubMed

60.

Giacomet, V., Penagini, F., Trabattoni, D., Viganò, A., Rainone, V., Bernazzani, G., et al. (2014). Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults. Vaccine,32(43), 5657–5661.PubMed

61.

Giuliano, A. R., Palefsky, J. M., Goldstone, S., Moreira, E. D., Penny, M. E., Aranda, C., et al. (2011). Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. New England Journal of Medicine,364(5), 401–411.PubMed

62.

Daley, E. M., Vamos, C. A., Thompson, E. L., Zimet, G. D., Rosberger, Z., Merrell, L., et al. (2017). The feminization of HPV: How science, politics, economics and gender norms shaped U.S. HPV vaccine implementation. Papillomavirus Research,3, 142–148.PubMedPubMedCentral

63.

Chido-Amajuoyi, O. G., Domgue, J. F., Obi-Jeff, C., Schmeler, K., & Shete, S. (2019). A call for the introduction of gender-neutral HPV vaccination to national immunisation programmes in Africa. The Lancet Global Health, 7(1), e20–e21.PubMed

64.

Katz, M. L., Krieger, J. L., & Roberto, A. J. (2011). Human papillomavirus (HPV): College male's knowledge, perceived risk, sources of information, vaccine barriers and communication. Journal of Men's Health, 8(3), 175–184.PubMedPubMedCentral

65.

Halkitis, P. N., Maiolatesi, A. J., & Krause, K. D. (In Press). The health challenges of emerging adult gay men: Effecting a change in healthcare. Clinical Review Articles.

Titel: Misinformation, Gendered Perceptions, and Low Healthcare Provider Communication Around HPV and the HPV Vaccine Among Young Sexual Minority Men in New York City: The P18 Cohort Study
verfasst von: Jessica Jaiswal
Caleb LoSchiavo
Anthony Maiolatesi
Farzana Kapadia
Perry N. Halkitis
Publikationsdatum: 04.02.2020
Verlag: Springer US
Erschienen in: Journal of Community Health / Ausgabe 4/2020
Print ISSN: 0094-5145
Elektronische ISSN: 1573-3610
DOI: https://doi.org/10.1007/s10900-019-00784-w

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Health Promotion Awareness in Barbershops and Salons: An International Cross-Sectional Survey in Japan and Thailand

Health Assessment of the Arab American Community in Southwest Chicago

Building a Culture of Health at the Neighborhood Level Through Governance Councils

Correlates of Health Promotion in a Community Sample of African American Churches

Incorporating Participant and Clinical Feedback into a Community-Based Participatory Research Study of Colorectal Cancer Among Alaska Native People

Associations Between Personal Protective Measures and Self-Reported Tick-Borne Disease Diagnosis in Indiana Residents